Nicholas Wareham
Has grant
Director
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Developing and disseminating tools for population health improvement: an online interactive atlas for identifying environmental change
Open Date: 2022-01-01
Close Date: 2023-12-31
Grant: Close
Prospective associations of major depressive disorder with atherosclerotic cardiovascular disease, cognitive impairment and mortality in the community
Open Date: 2022-01-01
Close Date: 2025-12-31
Grant: Close
The EPIC-Norfolk Study
Open Date: 2021-12-15
Close Date: 2022-03-30
Grant: Close
Investigating shared molecular pathways underlying cardiovascular diseases, diabetes and cancer
Open Date: 2020-06-30
Close Date: 2020-12-31
Grant: Close
Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life
Open Date: 2020-03-31
Close Date: 2025-03-30
Articles (25)
Background Previous studies on the reproducibility of 7-day accelerometer measurements have been limited by small sample sizes and short follow-up periods. We aimed to assess the long-term reproducibility of accelerometer-derived physical activity and sleep, and to illustrate the impact of regression dilution bias on the association between daily step count and coronary heart disease (CHD) in UK Biobank. Methods We analysed data from 3138 UK Biobank participants in the main accelerometry sub-study with up to four repeat accelerometer measurements after 3–4 years. Nine physical activity and sleep phenotypes were extracted to capture different movement behaviours. Reproducibility was assessed by using intraclass correlation coefficients (ICCs). The impact on disease associations was illustrated by considering daily step count and incident CHD using Cox regression (87 038 participants; 3879 CHD events), before and after correction for regression dilution. Results Among the 3138 participants, 51% were women and the mean (SD) age was 63.1 (9.4) years. Reproducibility was good for overall activity, with an ICC (95% confidence interval) of 0.75 (0.74–0.76), and moderate for other phenotypes, with ICCs ranging from 0.58 (0.56–0.59) for sleep efficiency to 0.69 (0.68–0.70) for sedentary behaviour. In our example, the inverse association between daily step count and CHD showed a 20% lower risk of CHD per usual 4000 steps after correcting for regression dilution compared with 13% before correction. Conclusion Accelerometer measurements are moderately reproducible and comparable to measures such as blood pressure. Correction for regression dilution bias is crucial to quantify associations of usual physical activity and sleep with disease risk.
Year:
2026
Aims Both plasma levels of remnant cholesterol and low-density lipoprotein (LDL) cholesterol levels are independent risk factors for atherosclerotic cardiovascular disease. However, only remnant cholesterol has consistently been associated with systemic inflammation. In this study, we aimed to assess the extent to which inflammation mediates the effect of remnant and LDL cholesterol on (non)fatal major adverse cardiovascular events (MACE), comprising of coronary artery disease and ischaemic stroke. Methods and results This prospective study included 16,445 participants without prior atherosclerotic cardiovascular disease from the EPIC-Norfolk study, with a mean age of 58.8 ± 9.1 years, of which 9,357 (56.9%) were women. Every 1 mmol/L higher remnant cholesterol was associated with 29.5% higher high-sensitivity C-reactive protein (hsCRP) levels [95% Confidence Interval (CI): 22.1, 37.4, P < 0.001], whereas LDL cholesterol was not significantly associated with hsCRP levels in the fully adjusted model. Additionally, each 1 mmol/L higher remnant cholesterol was associated with a hazard ratio (HR) of 1.31 (95% CI: 1.14, 1.50, P < 0.001) for MACE, compared with an HR of 1.21 (95% CI: 1.13, 1.31, P < 0.001) for LDL cholesterol. Mediation analysis showed that hsCRP mediated 5.9% (95% CI: 1.2, 10.6%, P < 0.001) of the effect of remnant cholesterol on MACE, whereas hsCRP did not mediate the effect of LDL cholesterol. Conclusion Plasma remnant cholesterol levels are independently associated with systemic inflammation and cardiovascular events. Inflammation, as measured with hsCRP, contributed minorly to the association between remnant cholesterol and MACE. This underscores the need to address both remnant cholesterol and systemic inflammation separately in the clinical management of cardiovascular disease. Lay summary This study finds that systemic inflammation does not influence the effect remnant cholesterol has on cardiovascular disease risk, suggesting the importance of addressing both remnant cholesterol and inflammation to manage cardiovascular health.
Year:
2026
Context Testosterone supplementation is increasingly widespread and has well-established beneficial effects on sexual function and metabolic health. However, there remains uncertainty regarding associated cardiovascular risks. Objective Human genetics studies demonstrated that Mendelian randomization approaches recapitulate the beneficial effects of testosterone therapy; here we apply this to cardiovascular disease. Design We performed a Mendelian randomization study to assess the causal effect of higher circulating testosterone on coronary artery disease (CAD). We also tested the phenotypic association between measured circulating testosterone and CAD in the cohort of men aged 40 to 69. Patients or Other Participants Testosterone genetic instrument data were derived from 425 097 European ancestry adults from the UK Biobank study and CAD from single nucleotide polymorphism-level summary statistics from 1 165 690 individuals in CARDIoGRAMplusC4D. Main Outcome Measure(s) CAD as defined in CARDIoGRAMplusC4D was the main outcome. In longitudinal analyses, CAD was defined according to medical records and self-report. Results We found that higher genetically predicted circulating testosterone conferred a higher risk of CAD in men [odds ratio (OR): 1.17, 95% confidence interval (CI) 1.07-1.27, P = 3.32 × 10−4]. There was no evidence of an effect in women (OR: 1.01, 95% CI 0.94-1.10, P = .73). The genetic association in men appeared to be mediated by higher blood pressure. In longitudinal observational analyses, a directionally opposite association was observed in men, likely arising due to confounding by type 2 diabetes and body mass index. Conclusion These data suggest that increased testosterone may increase the risk of cardiovascular disease and that this safety concern should be a focus in future clinical trials for testosterone supplementation.
Year:
2026
Mechanisms underlying sex differences in the development and prognosis of many diseases remain largely elusive. Here, we systematically investigated sex differences in the genetic regulation of plasma proteome (>5800 protein targets) across two cohorts (30,307 females; 26,058 males). Plasma levels of two-thirds of protein targets differ significantly by sex. In contrast, genetic effects on protein targets are remarkably similar across sexes, with only 103 sex-differential protein quantitative loci (sd-pQTLs; for 2.9% and 0.3% of protein targets from antibody- and aptamer-based platforms, respectively). A third of those show evidence of sexual discordance, i.e., effects observed in one sex only ( n = 30) or opposite effect directions ( n = 1 for CDH15). Phenome-wide analyses of 365 outcomes in UK Biobank did not provide evidence that the identified sd-pQTLs accounted for sex-differential disease risk. Our results demonstrate similarities in the genetic regulation of protein levels by sex with important implications for genetically-guided drug target discovery and validation.
Year:
2025
Comparisons of cardiorespiratory fitness across population studies are hindered by a lack of standardisation in exercise testing and reliance on estimation methods that assume steady-state exercise. We developed a generalised framework that standardises maximal oxygen consumption estimation by harmonising dynamic heart rate modelling with individualised calibration of exercise energetics. We constructed and evaluated the framework using submaximal and maximal tests (treadmill walking and running, cycle ergometer, stepping, overground walking) from 911 adults. Agreement between framework estimates and directly measured was strong (non-significant bias, Pearson’s r=0.80). We then applied both framework and canonical methods to estimate in 11,307 UK Fenland Study adults and examined associations with cardiometabolic risk. Framework-estimated was more strongly associated with blood glucose, fasting insulin, and high-density lipoprotein cholesterol (combined risk factor model AIC=125,743) compared to canonical estimates (AIC=129,227). The framework standardises fitness estimation across diverse tests, yielding a more reliable and comparable biomarker of cardiometabolic health.
Year:
2025
Introduction : Estimating free-living physical activity (PA) with continuous heart rate (HR) monitoring is challenging due to individual variation in the relationship between HR and energy expenditure. This variation can be captured through individual calibration with graded exercise tests, but structured tests with prescribed load require medical screening and are not always feasible in population settings. We present and evaluate an individual calibration method using HR response to a less demanding self-paced walk test. Methods : Six hundred and forty-three participants from the Fenland Study (Cambridgeshire, the United Kingdom) completed a 200-m self-paced walk test, a treadmill test, and 1 week of continuous HR and accelerometry monitoring. Mixed-effects regression was used to derive a walk test calibration model from HR response to the walk using treadmill-based parameters as criterion. Free-living PA estimates from the calibration model were compared with treadmill-calibrated and non-exercise-calibrated estimates. Results : Walk calibration captured 57% of the variance in the HR–energy expenditure relationship determined by the treadmill test. Applying walk calibration to data from free-living yielded similar PA estimates to those using treadmill calibration (52.7 vs. 52.0 kJ·kg −1 ·day −1 ; mean difference: 0.7 kJ·kg −1 ·day −1 , 95% confidence interval [−0.0, 1.5]) and high correlation ( r = .89). Individual differences were observed (root mean square error: 10.0 kJ·kg −1 ·day −1 ; 95% limits of agreement: −20.6, 19.1 kJ·kg −1 ·day −1 ). Walk calibration improved precision by 29% compared with nonexercise group calibration (root mean square error: 14.0 kJ·kg −1 ·day −1 ; 95% limits of agreement: −30.4, 24.5 kJ·kg −1 ·day −1 ). Conclusions : A 200-m self-paced walk test captures between-individual variation in the HR–energy expenditure relationship and facilitates estimation of free-living PA in population settings.
Year:
2024
Year:
2024
Childhood-onset type 1 diabetes (T1D) is associated with substantial psychiatric morbidity in later life, but it remains unknown whether these associations are due to common underlying biological mechanisms or the impacts of living with the condition and its treatment. Here, using Czech national register data, we identified children with T1D aged ≤14 years between 1994 and 2007 and estimated the risk of psychiatric disorders up to 24 years later. We found that children diagnosed with T1D had an elevated risk of developing substance use, mood, anxiety and personality disorders, and behavioral syndromes. Conversely, we found that children with T1D had a lower risk of developing psychotic disorders. In Mendelian randomization analysis, we found an association with schizophrenia, which, however, did not persist following multiple testing adjustment. The combined observational and Mendelian randomization evidence suggests that T1D diagnosis in childhood predisposes to far-reaching, extensive psychiatric morbidity, which is unlikely to be explicable by common underlying biological mechanisms. The findings of this study highlight that monitoring and addressing the mental health needs of children with T1D is imperative, whereas glucose dysregulation and/or inflammation implicated in schizophrenia pathogenesis warrants future research.
Year:
2024
Broad-capture proteomic platforms now enable simultaneous assessment of thousands of plasma proteins, but most of these are not actively secreted and their origins are largely unknown. Here we integrate genomic with deep phenomic information to identify modifiable and non-modifiable factors associated with 4,775 plasma proteins in ~8,000 mostly healthy individuals. We create a data-driven map of biological influences on the human plasma proteome and demonstrate segregation of proteins into clusters based on major explanatory factors. For over a third ( N = 1,575) of protein targets, joint genetic and non-genetic factors explain 10–77% of the variation in plasma (median 19.88%, interquartile range 14.01–31.09%), independent of technical factors (median 2.48%, interquartile range 0.78–6.41%). Together with genetically anchored causal inference methods, our map highlights potential causal associations between modifiable risk factors and plasma proteins for hundreds of protein–disease associations, for example, COL6A3, which possibly mediates the association between reduced kidney function and cardiovascular disease. We provide a map of biological and technical influences on the human plasma proteome to help contextualize findings from proteomic studies.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (96)
Xiaofeng Zhu
Professor
Case Western Reserve University
Harold Snieder
Scientific Staff
University Medical Center Groningen
Amy Bentley
National Human Genome Research Institute
Cristina Menni
King’s College London
Marcela Guevara
Instituto de Salud Pública de Navarra
Kathryn Martin
Senior Lecturer
University of Aberdeen
Ben Lacey
-
Nita G Forouhi
Programme Leader, MRC Investigator
University of Cambridge School of Clinical Medicine
Brenda WJH Penninx
Professor
-
Joseph McCormick
James H. Steele Professor
-
Renata L Riha
Honorary Reader (Associate Professor)
University of Edinburgh
Daniel Prieto-Alhambra
Professor (part-time)
Erasmus MC
Dana Dawson
Professor
University of Aberdeen
Yunhe Wang
University of Oxford
Anne Tjonneland
Professor
Københavns Universitet
Seunggeun Lee
Professor
Seoul National University
Matthijs Boekholdt
University of Amsterdam
Harry Hemingway
University College London
Vilmundur Gudnason
Professor
University of Iceland
Ayush Giri
Assistant Professor
Vanderbilt University Medical Center
Simon R. Cox
Personal Chair of Brain and Cognitive Ageing
University of Edinburgh
Serena Sanna
Scientific Staff
University Medical Center Groningen
Jean Adams
Programme leader and Professor
University of Cambridge
Clint Miller
Associate Professor
Stanford University
Jennifer Ann Smith
Professor
University of Michigan
Sarah Lewington
University of Oxford
Sarah Harris
University of Edinburgh
Adam Butterworth
Professor of Molecular Epidemiology
University of Cambridge
Patricia Munroe
Professor of Molecular Medicine
Queen Mary University of London
Ching-Ti Liu
Boston University
Erik S G Stroes
Amsterdam University Medical Centers
Ko Willems van Dijk
Professor
Leiden University Medical Center
Tomas Gonzales
University of Cambridge
Timo Lakka
Professor of Medical Physiology
University of Eastern Finland
massimo mangino
Honorary Senior Lecturer
King’s College London
Heming Wang
Assistant Professor
Brigham and Women's Hospital
Ilja Nolte
Senior Researcher of Statistical Genetics and Genetic Epidemiology
University Medical Center Groningen
Saima Afaq
Lecturer
University of York
Courtney Davis
University of South Australia
Heather M Highland
University of North Carolina at Chapel Hill
Marcus Dörr
University Medicine Greifswald
Paul de Vries
Assistant Professor
The University of Texas Health Science Center at Houston School of Public Health
Lisa de las Fuentes
Professor of Medicine and Biostatistics
Washington University School of Medicine
Maik Pietzner
Professor
Queen Mary University of London
Hannah Taylor
University of Oxford
Chloe Orkin
Dean for Healthcare Transformation
Queen Mary University of London
Reedik Mägi
Professor of Bioinformatics
University of Tartu
Albert Prats Uribe
University of Oxford
Junqing Xie
University of Oxford
Iris M. Heid
University of Regensburg
Rodney Scott
Prof. of Medical Genetics
University of Newcastle Australia
Myriam Fornage
-
Changwei Li
Associate Professor
University of Texas Southwestern Medical Center
Mary Feitosa
Associate Professor
Washington University School of Medicine
Debbie A Lawlor
Academic , Professor of Epidemiology, MRC Investigator and BHF Chair
University of Bristol
Sami Heikkinen
Research Director
University of Eastern Finland
Lorenz Risch
Titularprofessur für das Fach klinische Biochemie
University of Bern
Peter Y Liu
University of California
Tanika Kelly
Professor
University of Chicago
Nora Franceschini
Professor
University of North Carolina
Kari North
Professor
University of North Carolina at Chapel Hill
Jody Hoenink
Research Associate
University of Cambridge
Phyo K. Myint
University of Aberdeen
Kisung Nam
Seoul National University
Nick S Nurmohamed
University of Amsterdam
Jonathan Hodgson
Professor of Nutrition and Epidemiology
Edith Cowan University
Olli T. Raitakari
University of Turku
Amy L. Ahern
Research Professor
University of Cambridge
Michael Province
Professor, Head Division of Statistical Genomics
Washington University in St. Louis
Esther Molina-Montes
Universidad de Granada
Uwe Völker
Professor, Head of Department
Universitätsmedizin Greifswald
Quan Sun
Research Assistant Professor
University of Pennsylvania
John Attia
University of Newcastle Australia
Patrik Rorsman
Professor
University of Oxford
Nicholette Allred
Wake Forest Baptist Medical Center
Sébastien Thériault
Associate Professor
Laval University
W. James Gauderman
professor
University of Southern California
Mariaelisa Graff
Assistant Professor
University of North Carolina
Brian Cade
Investigator
Brigham and Women's Hospital
Steven B. Heymsfield
Pennington Biomedical Research Center
G. Kees Hovingh
University of Amsterdam
Terho Lehtimäki
University of Tampere
Laurens F. Reeskamp
University of Amsterdam
SINA A. GHARIB
University of Washington
Jeffrey Kroon
Assistant Professor, Staff
Amsterdam UMC Locatie AMC
Kenneth Westerman
Assistant Investigator
Massachusetts General Hospital
Jian'an Luan
University of Cambridge
Hugues Aschard
Head of Statical Genetics unit
Institut Pasteur
Raymond Noordam
Assistant Professor
Leiden University Medical Center
Jemma Hopewell
Professor of Precision Medicine & Epidemiology
University of Oxford
Victoria Keevil
Senior Clinical Lecturer and NIHR Exeter BRC Mid-Career Fellow
University of Exeter
Tammy Tong
University of Oxford
Valborg Gudmundsdottir
Research Assistant Professor
University of Iceland
Søren Brage
University of Cambridge
Danni Chen
Aarhus University
Aldo Grefhorst
-
Make your next move.
Prepare your application
Review drafts before you send them.